Document Detail


Alopecia areata. Update on therapy.
MedLine Citation:
PMID:  8435916     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The treatment of alopecia areata has changed markedly in the past decade. Several options are now available to the patient. It is the dermatologist's duty to inform the patient of all the options, their side effects, and their success rates. The final selection of treatment is a team decision between the patient, the patient's family, and the physician.
Authors:
J Shapiro
Related Documents :
25481306 - Communicating cancer treatment information using the web: utilizing the patient¿s persp...
25352356 - Impaired arousal at initial presentation predicts 6-month mortality: an analysis of 108...
25467176 - Comparison of a french pediatric type 1 diabetes cohort's responders and non-responders...
9100706 - The doctor's role in discussing advance preferences for end-of-life care: perceptions o...
18426596 - Diagnosis of ventilator-associated pneumonia: a systematic review of the literature.
18928936 - Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-r...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Dermatologic clinics     Volume:  11     ISSN:  0733-8635     ISO Abbreviation:  Dermatol Clin     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-03-25     Completed Date:  1993-03-25     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8300886     Medline TA:  Dermatol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  35-46     Citation Subset:  IM    
Affiliation:
Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Adrenal Cortex Hormones / therapeutic use*
Alopecia Areata / therapy*
Clinical Protocols
Humans
Immunosuppressive Agents / therapeutic use*
Irritants / therapeutic use*
Photochemotherapy*
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Immunosuppressive Agents; 0/Irritants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of vitiligo.
Next Document:  Management of hair loss in women.